HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Endovascular management of extensive lower extremity acute deep vein thrombosis with AngioJet rheolytic thrombectomy plus catheter-directed thrombolysis from contralateral femoral access.

AbstractPURPOSE:
The aim of the present study was to report the clinical outcomes of endovascular treatment for extensive lower limb deep vein thrombosis with AngioJet rheolytic thrombectomy (ART) plus catheter-directed thrombolysis (CDT) using a contralateral femoral approach.
METHODS:
A retrospective analysis of consecutive ART+CDT treatments in 38 deep vein thrombosis patients (LET I-III, from September 2014 to March 2016) was performed.
RESULTS:
The technical success rate was 100%. Complete lysis was achieved in 82% of LET III segments (calf veins), 87% of LET II segments (popliteal-femoral veins), and 90% of LET III segments (iliac veins). The best results were obtained in patients treated within seven days of symptom onset. During follow-up, well-preserved, competent femoral valves were observed in 86% of the patients, and recanalization of LET III, LET II, and LET I segments was achieved in 100%, 94%, and 91% of the patients, respectively. The post-thrombotic syndrome rate was 17% during a mean 20-month follow-up.
AuthorsGuang Liu, Zhen Zhao, Chaoyi Cui, Kaichuang Ye, Minyi Yin, Xaiobing Liu, Jinbao Qin, Xintian Huang, Min Lu, Mier Jiang, Weimin Li, Xinwu Lu
JournalPhlebology (Phlebology) Vol. 34 Issue 4 Pg. 257-265 (May 2019) ISSN: 1758-1125 [Electronic] England
PMID30049252 (Publication Type: Clinical Trial, Journal Article)
Topics
  • Acute Disease
  • Adult
  • Aged
  • Catheterization, Peripheral (instrumentation, methods)
  • Endovascular Procedures (instrumentation, methods)
  • Female
  • Femoral Vein (surgery)
  • Humans
  • Lower Extremity (physiopathology, surgery)
  • Male
  • Mechanical Thrombolysis (instrumentation, methods)
  • Middle Aged
  • Retrospective Studies
  • Venous Thrombosis (physiopathology, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: